Compare Merck & Co., Inc. (MRK) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Zillow Group Inc Class C — how do they compare? Merck & Co., Inc. trades at $148.16 (market cap $363.98B), while Zillow Group Inc Class C trades at $32.3 (market cap $7.26B). The key difference: Merck & Co., Inc. is far larger — about 50.1× Zillow Group Inc Class C's market cap, and Merck & Co., Inc. pays a 2.3% dividend while Zillow Group Inc Class C pays none. Which is the better fit depends on your goals.
| MRK | Z | |
|---|---|---|
Market Cap | $363.98B | $7.26B |
Sector | Health | Media |
52-Week High | $156.43 | $90.35 |
52-Week Low | $77.60 | $29.41 |
Enterprise Value | $410.75B | $7.14B |
Dividend Yield | 2.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MRK trades at $148.49, down 1.23% on the day, with a bullish technical signal from moving averages and support near $147. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.22. Revenue reached $65.01B in 2025, and the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline.
Outlook remains positive with a consensus price target of $157, offering ~6% upside. Risks include high P/E of 118.77 and competitive pressures in pharma. Institutional buying and a 67.57% buy rating from analysts support a constructive view, though net income margin of 4.77% warrants monitoring.
Zillow Group (Z) is trading at $32.36, down 6.45% over 24 hours, with a bearish technical signal. The stock shows mixed fundamentals: a high P/E of 139.74 reflects growth expectations, but net income margin is thin at 1.96%. Recent Q2 2026 earnings beat expectations, and revenue growth is projected from $2.6B in 2025 to $2.8B in 2026. News highlights include an FTC settlement and expansion of rental services.
The outlook is cautiously optimistic. Analyst consensus price target is $52.00, implying significant upside, but risks include a challenging housing market, ongoing profitability concerns, and recent legal settlements. The stock's current price near support at $32 suggests potential stability if fundamentals improve.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
